Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Frontiers in Pharmacology|May 30, 2023
Effects of adjuvant huaier granule therapy on survival rate of patients with hepatocellular carcinomaKe Shi, Yufei Bi, Xuanwei Zeng, et al.
Frontiers in Cellular and Infection Microbiology|January 30, 2023
Association between probiotic therapy and the risk of hepatocellular carcinoma in patients with hepatitis B-related cirrhosisKe Shi, Qun Zhang, Yi Zhang, et al.
Frontiers in Nutrition|May 22, 2023
Neutrophil-to-high-density-lipoprotein-cholesterol ratio and mortality among patients with hepatocellular carcinomaKe Shi, Jie Hou, Qun Zhang, et al.
Frontiers in Oncology|March 6, 2023
Development of a nomogram to predict the risk of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis on antiviralsKe Shi, Ping Li, Qun Zhang, et al.
Biomedicines|August 29, 2024
Prognostic Value of High-Density Lipoprotein Cholesterol in Patients with Overt Hepatic EncephalopathyKe Shi, Yufei Bi, Xiaojing Wang, et al.
Cancer Science|June 15, 2024
Prognostic and therapeutic potential of imbalance between PD-1+CD8 and ICOS+Treg cells in advanced HBV-HCCFengna Yan, Bingbing Zhu, Ke Shi, et al.
Bioorganic & Medicinal Chemistry|November 18, 2025
Exogenous/endogenous stimuli-responsive antitumor prodrugs advance precision chemotherapyLuo Wang, Jingao Li, Xuanwei Zeng, et al.
Chemical Communications (Cambridge, England)|November 24, 2023
Dual-responsive probe and DNA interstrand crosslink precursor target the unique redox status of cancer cellsDehao Yu, Luo Wang, Jingao Li, et al.
Frontiers in Medicine|February 17, 2025
Advances in intrahepatic and extrahepatic vascular dysregulations in cirrhotic portal hypertensionYanqiu Li, Bingbing Zhu, Ke Shi, et al.
Frontiers in Molecular Biosciences|December 9, 2024
Precision-engineered PROTACs minimize off-tissue effects in cancer therapyJianghua Shi, Luo Wang, Xuanwei Zeng, et al.
Pageof 2